3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
20
Carcinoma, Renal Cell
16
Liver Neoplasms
7
Leukemia, Myeloid, Acute
3
Thyroid Neoplasms
2
Financial Stress
2
Carcinoma
2
Patient Preference
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies
1
Carcinoma, Non-Small-Cell Lung
1
COVID-19
1
Adenoma, Islet Cell
1
Interventions
delta 24-sterol reductase
1
daratumumab
1
Validation Studies as Topic
1
Tape Recording
1
Sorafenib
1
Pilot Projects
1
Focus Groups
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Patient Preference
×
Sorafenib
×
Clear all
NCT02616692
2017-09-27
HCC Patient Preferences in Japan
Bayer
Completed
120 enrolled